ANAHEIM, CA, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of…
New interim analysis of the Phase 3 CARES study showed complete or partial response in 78% of the 18 patients…
Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., April 27, 2022 (GLOBE NEWSWIRE) --…
Live event in New York City and webcast to start at 8:30 a.m. ETBOSTON, April 27, 2022 (GLOBE NEWSWIRE) --…
Novo Nordisk's Articles of Association 2022 after capital reduction, 27 April 2022 Attachment NN_Articles_of_Association_2022_After CapReduction
Bagsværd, Denmark, 27 April 2022 – At Novo Nordisk’s Annual General Meeting on 24 March 2022, it was decided to…
BioXp™ system and RapidAMP™ cell-free DNA kit allow scientists to synthesize, clone, and amplify antibody-variable regions based on a digital…
NASHUA, N.H., April 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection…
Key Opinion Leaders participating will be Stuart Goldstein, MD, Cincinnati Children’s Hospital and Lakhmir Chawla, MD, former Chief of the Division…
- Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress -…